Objective: Breast cancer patients are associated with an increased risk for committing suicide. The purpose of this study was to study the trends in the incidence of suicide mortality and identify pertinent risk factors among patients with breast cancer. Results: Overall, 474 128 patients were identified of which 773 had committed suicide. There were no significant differences in the incidence of suicide mortality over the last 3 decades (1984-1993: 0.14%, 1994-2003: 0.16%, 2004-2013: 0.17%, P = 0.173). On logistic regression, younger age (<30 y: OR 6.34, 95% CI: 1.98-20.33, P = 0.002; 30-49 y: OR 10.64, 95% CI:
| BACKGROUND
Suicide is the 10th leading cause of death in the United States, accounting for 1.6% of all deaths 1 in 2014, and a decade-long strategy has been implemented by the US Surgeon General to prevent suicide mortality. 2 Patients with cancer are at considerable risk for committing suicide, with a 2-fold higher risk of suicide compared to the general population. This may be related to several associated comorbidities, such as depression, pain, surgery-related anxiety, financial issues, and side effects from treatment. [3] [4] [5] Lung cancer portends the greatest suicide mortality risk, with 5.74 times higher risk of suicide compared to the general population, followed by stomach and oropharyngeal cancers, with 4.68 and 3.66 times higher risk, respectively. Suicide risk for breast cancer patients has been reported to be 1.35 to 1.37 times higher than that of the general population in earlier studies. 3, 6 In particular, breast cancer survivors constitute a sensitive population whose quality of life is considerably affected and is reportedly worse compared to that of other female cancer survivors, 7 while their cognitive functions and memory performances may also be compromised. 8, 9 Long-term hormonal therapy may also contribute towards lower quality of life. 10 All these factors may undermine patients' psychological status and predispose towards depression and suicidal ideation. In fact, the rate of depression among breast cancer patients has been estimated 11 at 52.7% and is highest during the first year after diagnosis, 12 while approximately 1 of 10 patients reports suicidal ideation 1 year after breast cancer surgery. 13 Genetic associations have also been reported, with the brain-derived neurotrophic factor met allele having been associated with an increased risk for suicidal ideation among breast cancer patients. 13 The purpose of this study is to identify the trends in the incidence of suicide mortality among breast cancer patients in the United States over the past decades and associated risk factors for recognizing patients at risk. Table S1 ). 
| METHODS

| Risk factors of suicide mortality in the entire cohort
On univariate analysis, the rates of suicide mortality were significantly higher in younger patients, male patients, patients of nonwhitenonblack race, single patients, those that had undergone surgery, those with lower tumor grades, and earlier disease stages. In terms of time elapsed from diagnosis, the highest rates of suicide mortality were identified during the first years after cancer diagnosis.
Multivariable logistic regression was then performed including factors that were significant on univariate analysis. In terms of demo- Table 2 ). An analysis of the suicide rates per stage/grade and year of follow-up revealed that increasing stage was significantly associated with higher suicide rates at years 1 to 3 after diagnosis, while higher tumor grade was significantly associated with higher suicide rates at the first year after diagnosis (see Table S2 ). Cancer patients constitute a high-risk population for committing suicide, with this risk being evident immediately after diagnosis 16, 17 and continuing into several years of follow-up. 18 In a report by Schairer and colleagues, 6 containing data from 1953 to 2002, the cumulative suicide prevalence for breast cancer patients was 0.20% at 30 years after diagnosis, a rate similar to the 0.16% rate we identified and close to the rates that were reported from Scandinavian countries in the same study (Norway 0.11%, Sweden 0.16%, Finland 0.18%, Denmark 0.24%), but lower compared to the suicide rate reported from Switzerland (0.5%). 6, 19 Rather surprisingly, the aforementioned study by Schairer and colleagues found that African American patients were at higher risk for committing suicide, which is contradictory to our results. However, these differences could potentially be ascribed to the inclusion of a lower number of African American patients committing suicide in the previous study. Moreover, our findings are consistent with previous reports by the Center for Disease Control that African Americans have the lowest risk for committing suicide among all races in the United States. 20 Earlier disease stage and lower tumor grade were also found to be associated with higher risk for committing suicide, which could in part be explained by the fact that all patients in this study had died, regardless of cause of death. In this way, breast cancer is more likely to be the cause of death in patients with more aggressive disease compared to those with less aggressive disease.
| Subanalysis of patients diagnosed from 2004 to 2013
To examine whether longer follow-up in patients with less aggressive disease could account for these differences, an analysis of suicide rates per stage/grade and year of follow-up was performed, where significant differences in suicide rates were identified only for the first 3 years after diagnosis for disease stage and the first year after diagnosis for tumor grade. This result may be explained by the fact that during the first few years after diagnosis, a higher proportion of patients with aggressive disease is expected to die of their disease rather than other causes of death, including suicide. Time elapsed from cancer diagnosis has previously been recognized as a major risk factor for committing suicide, and this study identified an almost 5-fold risk of suicide mortality during the first year after diagnosis, which is consistent with previous findings. 16 Various other high-risk patient groups were identified in this study. Single or separated marital status was associated with an increased risk for committing suicide, which has also been reported for the general population. 21, 22 Nonmarried breast cancer patients have also been associated with an increased risk for having suicidal ideation compared to married breast cancer patients, 13 but marital status has not been examined in population studies of suicide mortality from other countries to allow comparisons. Interestingly, married patients were more likely to commit suicide than single patients on univariate analysis in the subset of patients diagnosed from 2004 to 2013, but this result was not significant on multivariate analysis, so this finding may be attributed to the smaller sample size in this subset of patients. Male sex also conferred an increased suicide risk, which is concurrent with the fact that men are more likely to commit suicide compared to women. 23 In addition, a substantial difference between the awareness for female and male breast cancers has been described, and as a result access to support groups for the often forgotten male population may be suboptimal. 24 Furthermore, younger and middle- aged patients were found to commit suicide more often than older patients, which is consistent with previous findings that younger women with breast cancer fare worse in terms of functional status when compared to older women. 25 Older patients might also be more familiarized with the idea of death and, for this reason, may cope relatively better with a cancer diagnosis. 26 Nonwhite/nonblack race was also found to be an independent risk factor for committing suicide, and previous studies have reported that these racial groups are associated with increased risk for both depression and suicide. 27, 28 Lastly, the differences between states tended to be on par with the respective differences in suicide rates for the states included in our analysis. 29 Cancer-directed surgery may also increase suicide risk, presumably because of the adverse psychological morbidity of mastectomy and the associated alterations in body image. 30, 31 Finally, patients with PR+ tumors were also found to be at higher risk for committing suicide compared to those with PR− tumors, which could potentially be related to the complex relationship that exists between progesterone and mood disorders, 32 but further studies may be required to explain this association. The reduced number of patients in the group of patients diagnosed from 2004 to 2013 compared to those of other periods is explained by the fact that all patients in the study had died.
As a result, with shorter follow-up the number of dead patients during this period is expected to be smaller compared to the same number for previous decades.
5 | CONCLUSIONS
| Study limitations
Regarding potential study limitations, suicide is a complex phenomenon, and the available data could not account for various important patient characteristics that could explain some of the suicide burden noted in our analysis, such as psychosocial stressors, history of mood disorders, and education level. Moreover, data on chemotherapy regimens and timing of administration were also lacking. Additionally, our study is limited by its retrospective character, because data were collected prior to our analysis, and the use of a large multi-institutional database that may predispose towards potential miscoding. 
| Clinical implications
